1.
Nakasone MA, Lewis TA, Walker O, et al. Structural Basis for the Inhibitory Effects of Ubistatins in the Ubiquitin-Proteasome Pathway. Structure. 2017;25(12):1839-1855.e11. doi:10.1016/j.str.2017.10.007.
1.
Zhang J-Y, Wang M, Tian L, et al. modifies -induced kidney disease risk. Proc Natl Acad Sci U S A. 2018;115(13):3446-3451. doi:10.1073/pnas.1716113115.